Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB019337-Hydroxystaurosporine1Completed1
DB12442Alvespimycin1Completed1
DB00112Bevacizumab1Completed1
DB00002Cetuximab1Completed2
DB00530Erlotinib1Completed2
DB01590Everolimus1Completed1
DB00099Filgrastim1Completed1
DB00544Fluorouracil1Completed1
DB01005Hydroxyurea1Completed1
DB00762Irinotecan1Completed1
DB00112Bevacizumab1 / 2Completed1
DB00002Cetuximab1 / 2Completed1
DB00530Erlotinib1 / 2Completed1
DB09150Fludeoxyglucose F-181 / 2Active Not Recruiting1
DB09502Fludeoxyglucose F-181 / 2Active Not Recruiting1
DB00112Bevacizumab2Completed1
DB00317GefitinibNot AvailableCompleted1